INGHAM EILEEN,INGHAM EILEEN,WILSHAW STACY-PAUL,WILSHAW STACY-PAUL,FISHER JOHN,FISHER JOHN
申请号:
PL11764272
公开号:
PL2621548T3
申请日:
2011.09.26
申请国别(地区):
PL
年份:
2017
代理人:
摘要:
A product comprising a natural acellular xenogenic vascular tissue matrix having at least an 80% reduction in DNA content as compared to an untreated control vascular tissue matrix and being antigenically inert by being substantially free of epitopes capable of reacting with pre-formed human antibodies and also without having the ability to substantially activate complement. The invention also includes methods of preparing such products and uses of the products especially in bypass surgery.